Biotron Limited Stock Analysis

Biotron Pink Sheet Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Biotron Limited had not issued any dividends in recent years. The entity had 140:127 split on the 15th of May 2018. Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Biotron Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Biotron Limited please contact the company at 61 2 9300 3344 or go to https://www.biotron.com.au.

Biotron Limited Investment Alerts

Biotron Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotron's market, we take the total number of its shares issued and multiply it by Biotron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biotron Profitablity

The company has Profit Margin (PM) of (1.78) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.78) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.78.

Technical Drivers

As of the 1st of December, Biotron shows the Mean Deviation of 3.09, standard deviation of 9.39, and Risk Adjusted Performance of (0.07). Biotron Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Biotron Limited variance and value at risk to decide if Biotron Limited is priced correctly, providing market reflects its regular price of 0.0125 per share. As Biotron Limited appears to be a penny stock we also recommend to validate its jensen alpha numbers.

Biotron Limited Price Movement Analysis

Biotron Predictive Daily Indicators

Biotron Forecast Models

Biotron's time-series forecasting models are one of many Biotron's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotron's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Biotron prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotron shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Biotron. By using and applying Biotron Pink Sheet analysis, traders can create a robust methodology for identifying Biotron entry and exit points for their positions.

When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.